Langer Dennis
CIK 0001274225
Director
Filings
9
Latest Feb 6, 2026
Issuers covered
2
Showing
9 of 9
Page 1
Track record
2 of 2 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 2 | 50% | +7.5% | +7.5% | +19.4% | -4.5% |
| 90 days | 2 | 0% | -13.6% | -13.6% | -10.7% | -16.6% |
| 180 days | 2 | 0% | -35.2% | -35.2% | -12.5% | -57.9% |
| 365 days | 1 | 100% | +66.2% | +66.2% | +66.2% | +66.2% |
Issuers
Companies where Langer Dennis has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| QNRX | Quoin Pharmaceuticals, Ltd. | 7 | Feb 6, 2026 |
| MYGN | Myriad Genetics Inc | 2 | Jun 30, 2022 |
All filings
9 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|